16 hours IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva Investor's Business Daily
Catalyst struck a deal Wednesday with Teva that will prevent the generic drugmaker from knocking off Firdapse until 2035.
The post IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva appeared first on Investor's Business Daily.